Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin launches Mirabegron Extended-Release Tablets in the US
Mirabegron Extended-Release Tablets, 50 mg had estimated annual sales of $ 1,600 million in the US (IQVIA MAT July 2024)
Agilent – Advance Your Peptide Product Commercialization
Synthetic peptide therapeutics, encompassing a range of artificially created peptides, have emerged as a significant area of…
STEER World appoints Dhiraj Tiwari as CFO
Tiwari brings 20+ years of extensive executive-level financial expertise across various industries including Pharma, Media,…
WHO’s mpox response aims to reduce disease burden, provides scope for developers
There is a huge opportunity for developers and manufacturers to advance novel prophylactic and treatment options, says GlobalData
ENTOD’s PresVu eye drops gain DCGI approval
PresVu aims to reduce dependency on reading glasses for individuals affected by presbyopia
MK Hamied, Vice Chairman and Non-Executive Director, Cipla steps down
Cipla announces appointment of Kamil Hamied as Non-Executive Director
Making sustainability sustainable
Driven by stringent regulations, rising investor expectations, consumer demand, and operational considerations, Viveka…
Zydus gains final USFDA approval for Amantadine extended-release capsules 68.5 mg and tentative…
Eligible for 180 days of generic drug exclusivity for Amantadine extended release capsules, 68.5 mg
Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
Zeon Lifesciences secures patent for phyto-product extraction method
Zeon receives patent for a new extraction process of Annona muricata, improving the efficacy and purity of anti-cancer…